FDA Grants First-Ever Approval to an RNA-Based Diagnostic for Colorectal Cancer – MedCity News
Diagnostics startup Geneoscopy earned its first-ever FDA approval this week.
The St. Louis-based company received approval for ColoSense, its noninvasive colorectal cancer screening test. The test — which the FDA designated as a breakthrough device…
Continue Reading
